Session 9: Protecting Confidential Information in Summaries of Trial Results
Robert Paarlberg, MS
Global clinical data disclosure and transparency requirements and initiatives have resulted in massive amounts of clinical data in the public domain. Local county and regional data protection regulations safe guard personal identifiable information from public disclosure. This session will explore how patient identifiable data are being protected in this global clinical disclosure/transparency ecosystem.
Learning Objective : At the conclusion of this session, participants should be able to:
- Discuss the interplay between disclosure/transparency requirements and country/regional data protection regulations
- Identify stakeholder perspectives
- Implement best practices
Protecting Confidentiality: Public and Patient Perceptions and Best Communication Practice: Behtash Bahador, MS
Director, Health Literacy
Center for Information and Study on Clinical Research Participation (CISCRP), United States
Common Challenges Under GDPR for Data Disclosure and Transparency: Michael A. DiMaio, JD
Ropes & Gray LLP, United States
Anonymisation and Public Trust (Remote Presentation): Brendan Barnes
Director, Data Protection & IP
Have an account?